Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making

• Status: Recruiting
• Trial end date: 2023-01-03
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate the maximal cycle of effective neoadjuvant chemotherapy for resectable gastric cancer, to determine what is the best cycle of neoadjuvant chemotherapy for the patients who receive neoadjuvant chemotherapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking University

Criteria

Inclusion Criteria:

1. Histologically proven adenocarcinoma of the stomach

2. Clinical cT2N+M0,or cT3-4a/N+M0 disease, confirmed by upper gastrointestinal endoscopy and abdominal computed tomography (CT) and MRI and laparoscopy.

3. Receive neoadjuvant chemotherapy in clinical

Exclusion Criteria:

1. Contraindication for chemotherapy

2. Contraindication for surgery

3. Clinically apparent distant metastasis